Veon (VEON) Cash & Equivalents (2009 - 2025)

Veon (VEON) has reported Cash & Equivalents for 17 consecutive years, with $1.7 billion the latest figure, recorded in Q4 2025.

• Cash & Equivalents for Q4 2025 came in at $1.7 billion, up 2.55% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.7 billion (up 2.55% YoY), and the FY2025 annual result was $1.7 billion, up 2.55% from the prior year.
• Cash & Equivalents was $1.7 billion for Q4 2025 at Veon, up from $1.3 billion in the prior quarter.
• Over five years, Cash & Equivalents peaked at $2.5 billion in Q2 2023 and troughed at -$92.0 million in Q3 2021.
• Average Cash & Equivalents over 5 years is $1.1 billion, with a median of $1.2 billion recorded in 2021.
• Year-over-year, Cash & Equivalents plunged 108.51% in 2021 and jumped 42125.0% in 2024.
• Over 5 years, Cash & Equivalents stood at $54.0 million in 2021, then tumbled by 88.89% to $6.0 million in 2022, then tumbled by 33.33% to $4.0 million in 2023, then surged by 42125.0% to $1.7 billion in 2024, then increased by 2.55% to $1.7 billion in 2025.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $1.7 billion in Q4 2025, $1.3 billion in Q2 2025, and $1.7 billion in Q4 2024.